Algo version: 0.98b
3D Medicines Inc is listed at the HKSE Exchange
3D Medicines Inc [1244.HK]
HKSE Sector: Healthcare Industry:Biotechnology

Is 3D Medicines Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for 3D Medicines Inc 10 years ago, but if you had invested on Thursday 15th of December 2022 when the price was HKD31.45, you would have made a loss of HKD-29.46 per share or -93.67%

Yes, the average daily trading liquidity for 3D Medicines Inc is HKD594 962 thousand. You should therefore be able to get in and out of your positions relatively fast.

3D Medicines Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for 3D Medicines Inc to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.